Cubic Pharmaceuticals: Announcement on the completion of the shareholder reduction plan
Securities code: 003020 Securities abbreviation: Cubic Pharmaceuticals Announcement number: 2025-068
Hefei Cube Pharmaceutical Co., Ltd.
Announcement on the completion of the implementation of the shareholder reduction plan
Ms. Gao Meihua, a shareholder of the company, guarantees that the information provided to the company is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Special tips:
Hefei Cubic Pharmaceutical Co., Ltd. (hereinafter referred to as "Lifang Pharmaceutical" or the "Company") disclosed the "Pre-Disclosure Announcement on the Reduction of Shares by Some Directors, Supervisors, Senior Management and Shareholders" (Announcement Number: 2025-043) on June 6, 2025. The company's shareholder, Ms. Gao Meihua, plans to reduce her holdings of the company's shares by no more than 300,000 by centralized bidding or block trading within 3 trading days from the date of disclosure of the reduction plan. shares (accounting for 0.16% of the company’s total share capital). Recently, the company received the "Notification Letter on the Completion of the Implementation of the Shareholding Reduction Plan" issued by Ms. Gao Meihua, and learned that Ms. Gao Meihua's shareholding reduction plan has been completed. The specific situation is now announced as follows:
1. Shareholding reduction by shareholders
- Shareholding reduction by shareholders
Average price of reduction of holdings Number of shares of reduction of holdings
Name of shareholder Shareholding reduction method Shareholding reduction period Shareholding reduction ratio (yuan/share) (10,000 shares)
Centralized bidding from July 28, 2025 to
Gao Meihua 29.71 30 0.16% transaction August 29, 2025
Sources of reduced shareholdings: shares held before the company’s initial public offering and shares obtained by converting capital reserve funds into share capital.
Price range for reduction: 27.44 yuan/share-37.00 yuan/share.
The average price of reduction is the total reduction transaction amount divided by the quantity of reduction.
- Shareholding status of shareholders before and after this reduction
Shares held before this shareholding reduction. Name of shareholder holding shares after this shareholding reduction. Nature of shares.
Number of shares (shares) Proportion to total share capital Number of shares (shares) Proportion to total share capital
Total shares held 6,444,703 3.37% 6,144,703 3.23% Gao Meihua Among them:
6,444,703 3.37% 6,144,703 3.23%
shares without sale limit
Shares held before this shareholding reduction. Name of shareholder holding shares after this shareholding reduction. Nature of shares.
Number of shares (shares) Proportion of total share capital Number of shares (shares) Proportion of total share capital Shares with sales restrictions 0 0.00% 0 0.00%
Note: The company disclosed the "Announcement on the Completion of the Repurchase and Cancellation of Part of the Restricted Stocks Under the 2022 Restricted Stock Incentive Plan" on July 25, 2025 (Announcement Number: 2025-048). On July 23, 2025, the cancellation of 1,078,318 restricted shares was completed. After the repurchase and cancellation, the company's total share capital was reduced from 191,260,500 shares to 190,182,182 shares.
2. Other related instructions
Ms. Gao Meihua’s shareholding reduction complies with the provisions of laws, regulations and normative documents such as the Securities Law of the People’s Republic of China, the Stock Listing Rules of the Shenzhen Stock Exchange, the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations of Main Board Listed Companies, the Interim Measures for the Management of Share Reductions by Shareholders of Listed Companies, the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 18 - Share Reductions by Shareholders, Directors and Senior Management.
Ms. Gao Meihua’s shareholding reduction in the company has been disclosed in advance in accordance with relevant regulations. This reduction is consistent with Ms. Gao Meihua’s previously disclosed intention and shareholding reduction plan. There is no violation of the disclosed shareholding reduction plan. This shareholding reduction plan has been implemented.
Ms. Gao Meihua’s commitment to reduce holdings in the “Initial Public Offering and Listing Announcement” is as follows:
After the shareholding lock-up period ends, I will comprehensively consider various factors such as personal and family financial needs and investment arrangements to determine whether to reduce the company's shares. If I determine to reduce the company's shares in accordance with the law, I shall make an announcement three trading days in advance.
As of the disclosure date of this announcement, Ms. Gao Meihua has strictly fulfilled the above commitments, and there is no violation of relevant commitments in this holding reduction.
- The implementation of Ms. Gao Meihua’s shareholding reduction plan will not result in a change in the company’s control, nor will it have a significant impact on the company’s governance structure and future continued operations.
3. Documents for reference
- "Notification Letter on the Completion of the Implementation of the Share Reduction Plan" provided by shareholder Ms. Gao Meihua.
Announcement is hereby made.
Board of Directors of Hefei Cube Pharmaceutical Co., Ltd.
September 3, 2025